Alterity Therapeutics Limited, a development stage enterprise, has announced the application for quotation of additional securities on the ASX. The announcement, dated April 29, 2024, specifies that 7,097,419 ordinary fully paid shares will be quoted following the exercise of options or conversion of other convertible securities. These shares were issued on April 22, 2024, at an issue price of AUD 0.007 each. The new securities will rank equally with the existing issued securities in that class. Following this quotation, Alterity Therapeutics' issued capital will include over 5 billion ordinary shares and a variety of options with different expiration dates and exercise prices.

Alterity Therapeutics Limited, a development stage enterprise, has announced the application for quotation of additional securities on the ASX. The announcement, dated April 29, 2024, specifies that 7,097,419 ordinary fully paid shares will be quoted following the exercise of options or conversion of other convertible securities. These shares were issued on April 22, 2024, at an issue price of AUD 0.007 each. The new securities will rank equally with the existing issued securities in that class. Following this quotation, Alterity Therapeutics' issued capital will include over 5 billion ordinary shares and a variety of options with different expiration dates and exercise prices.